None listed
Conditions
Interventions
Ingestion of Lactobacillus amylovorus CP1563for 3 weeks, Wash out 1 week and ingestion of Placebo for 3 weeks.
Ingestion of placebo for 3 weeks, Wash out 1 week and ingestion of Lactobacillus amylovor
Sponsors
Fukuoka university
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Subjects who can make self-judgment and are voluntarily giving written informed consent. 2) Males whose age 40 to 59 years old for Japanese.
Exclusion criteria
Exclusion criteria: 1. Subjects who have diabetes in the second degree. 2. Subjects who have past surgical historyof gastroenterological surgery. 3. Subjects who use pharmaceuticals regularly. 4. Subjects who have an acute disease like a inflammation of the upper airway or acute gastroenteritis. 5. Subjects who excessive alcohol intake and who have a smoking habit. 6. Subjects with allergies of lactobacillus, milk, soy and citrus. 7. Subjects who is irregular eating habits. 8. Subjects who are participating or will participate other clinical trials. 9. Others who have been determined ineligible by principal investigator or subinvestigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Energy expenditure, Fat oxidation | — |
Countries
Japan
Contacts
Public ContactYoichi Hatamoto
Fukuoka univercity Faculty of Sports and Health Science
Outcome results
None listed